Article information
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
A.T.S. The American Lung Association Conference on reestablishing control of tuberculosis in the United States. Conference report.
Am J Respir. Crit. Care Med, 154 (1996),
[2.]
G. Antonucci, E. Girardi, M.C. Raviglione, G. Ippolito.
Risk factors for tuberculosis in HV-infected persons.
JAMA, 274 (1995), pp. 143
[3.]
P.F. Barnes, A.B. Bloch, P.T. Davidson, J.J. Snider De.
Tuberculosis in patients with the HIV infection.
N. Engl. J. Med., 324 (1991), pp. 1644
[4.]
Center of Diseases Control.
Acquired Immunodeficiency Syndrome.
Data as at 30 June 1996. Weekly Epidemiological Record, 71 (1996), pp. 205
[5.]
Center of Diseases Control.
National Action Plan To Control Multi-Drug-Resistant Tuberculosis.
MMWR, 41 (1992),
[6.]
Centro De Vigilância Epidemiológica Pas Doenças Transmissímis - SIDA A situação em Portugal a 31 de Dezembro de 1984. Doc.83.
[7.]
Centro De Vigilância Epidemiológica Das Doenças Transmissíveis - SIDA A situação em Portugal a 30 de Junho de 1996. Doc.96.
[8.]
Direcção Geral De Saúde. Estatisticas. Doenças de declaração obrigatória: 1980/1994.
[9.]
P.J. Dolin, M. Raviguone, A. Kochi.
Global tuberculosis incidence and mortality during 1980-2000.
Bull of the WHO, 72 (1984), pp. 213
[10.]
D.A. Enarson, J. Grosset, A. Mwinga, E.S. Hershfield, R. O'Brien, S. Cole, L. Riechman.
The challenge of tuberculosis: statements on glogal control and prevention.
The Lancet, 346 (1985), pp. 809
[11.]
A. Fernandes, R. Vaz, A. Noya.
AIDS.
[12.]
T.R. Friedden, T. Sterling, A. Pablo-Mendez, et al.
The emergence of drug resistance tuberculosis in N.Y. City.
N. Engl. J. Med, 328 (1993), pp. 521
[13.]
M.L.G. Garcia, J.L.V. Gomez, M.C.G. Sancho, R.A.S. Alvarez, F. Zacarias, J.S. Amor.
Epidemiology of AIDS and Tuberculosis.
Bull PAHO, 29 (1995), pp. 37
[14.]
M.D. Iseman, D.L. Cohn, J.L. Sbarboro.
Directly observed treatment of tuberculosis: we can't afford not to try it.
N. Engl. J. Med., 328 (1993), pp. 576
[15.]
A.S. Malin, K. McAdam, Pwj.
Escalating threat from tuberculosis: the third epidemic.
Thorax, 50 (1995), pp. 837
[16.]
H. Marques, A.P. Cost, C. Alves, J.G. Duarte, M.J.M. Gomes.
Tuberculose e Toxicodependência - Revisão Clínica.
Revista Portuguesa de Pneumologia, II (1996), pp. 331
[17.]
Mendes B., Gomes C., Henriques J., Pestana E., Miragaia I., Matos C., Dionísio J., Rosa P., Pádua M., Pina J., Gomes M.J.M. Estudo da prevalência da resistência aos antibacilares. Revista da Sociedade Portuguesa de Pneumologia. Aceite para publicação.
[18.]
J.F. Murray, S.M. Garay, P.C. Hopewell, J. Mills, G.L. Snider, D.E. Stover.
Pulmonary complications of the Acquired Immunodeficiency Syndrome: an update. Report on the second National Heart, Lung and Blood Institute work-shop.
Am. Rev. Respir. Dis., 136 (1987), pp. 504
[19.]
J.P. Narain, M.C. Raviglione, A. Kochi.
HIV-associated tuberculosis in developing countries: epidemiology and stategies for prevention.
Tubercle and Lund Disease, 73 (1992), pp. 311
[20.]
T. Paixão.
Comumcação pessoal.
(1986),
[21.]
M.C. Raviglione.
Tuberculosis and HIV,
[22.]
M.C. Ravigiione, H.L. Rieder, K. Snblo, A.G. Khomenko, K. Esteves, A. Kochi.
Tuberculosis trends in Estern Europe and the former USSR.
Tubercle and lund Disease, 75 (1984), pp. 400
[23.]
M.C. Raviglione, P. Sudre, H.L. Rieder, S. Spinaci, A. Kochi.
Secular trends of tuberculosis in Western Europe.
Bull WHO, 71 (1983), pp. 297
[24.]
H.L. Rieder, J.P. Zellweger, M.C. Raviglione, S.T. Keizer, G.B. Migliori.
Tuberculosis control in Europe and international migration.
European Respiratory Journal, 7 (1994), pp. 1545
[25.]
A. Rouillon, D.A. Enarson, J. Chretien.
Epidemiologie de la tuberculose dans le Monde.
Encycl. Méd. Chir., 32 (1996),
[26.]
P.A. Selwyn, D. Hartel, V.A. Lewis.
A prospective study of the risk of tuberculosis among intravenous drug users with HIV infection.
N. Engl. J. Med., 320 (1989), pp. 545
[27.]
G. Slutkin, J. Leowski, Mann.
The effects of the AIDS epidemic on the tuberculosis problem and tuberculosis programmes.
Bull. I. U.A.T.L.D, 63 (1988), pp. 21
[28.]
P. Sudre, B.J. Hirschel, J.M. Gatell, S. Scwander, S. Vella, C. Katlama, B. Ledergerber, A. ArminioMonforte, F.D. Goebel, P.O. Pehrson, C. Peder-Sen, J.D. Lundgren.
Tuberculosis among European patients with the acquired immune deficiency syndrome.
Tubercle and Lund Disease, 77 (1996), pp. 322
[29.]
C.P. Theuer, R.E. Chaisson, G.F. Schecter, P.C. HopeWell.
Human Immunodeficiency virus infection in tuberculosis patients in San Francisco.
Am. Rev. Respir. Dis., 137 (1988), pp. A121
[30.]
B.P. Vareldzis, J. Grosset, I. Dekantor, J. Crofton, A. Laszlo, M. Felten, M.C. Raviglione, A. Kochi.
Drug-resistant tuberculosis: laboratory issues.
Tubercle and Lund Disease, 75 (1984),
[31.]
I. Ziment.
Epidemiology of mycobacterial infection.
European Respiratory Review, 5 (1995), pp. 91
Copyright © 1997. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options